FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 345:1652 November 29, 2001 Number 22

	Since this article has no abstract, we have provided an extract of the first 100% of the full text and any section headings.

	Full Text PDF Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Thomsen, O. O.

A Comparison of Budesonide and Mesalamine for Active Crohn's Disease . On page 372, the sentence that begins on line 8 of the right-hand column should have read, "The median time to remission was also shorter in the budesonide group than in the mesalamine group (28 vs. 58 days, P=0.12)," not "(28 vs. 84 days, P =0.04)." as printed.

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.